Artificial and augmented intelligence are already helping healthcare improve clinically, operationally and financially—and there is extraordinary room for growth. Success starts with leadership, vision and investment and leaders tell us they have all of the above. Read more

Here is an overview of top priorities, barriers to adoption and the mindset of leadership. Healthcare organizations are focused, creating plans and paths to make AI happen. Read more

Gilead Sciences, a Foster City, California-based biopharmaceutical company, is scheduled to present new AI-powered research related to nonalcoholic steatohepatitis (NASH) at The Liver Meeting 2019 in Boston.

Artificial and augmented intelligence are poised to revolutionize healthcare and medicine. Read more

Deep learning techniques have shown potential to change cardiac MRI forever, according to a new analysis published in the American Journal of Roentgenology. However, the authors wrote, it is also important to remember deep learning’s current limitations.

PathAI, a Boston-based AI technology company focused on pathology solutions, announced it has raised $75 million in Series B funding.

RadNet has announced a new partnership with Santa Clara, California-based to improve mammography screening rates and breast cancer care through the use of AI and other advanced technologies.

It is traditionally believed that men and women experience angina—the pain associated with coronary artery disease—in different ways, with men feeling it in their chest and women feeling it in their arms and back.

Radiologists are in a position to demonstrate their value and lead the implementation of AI in healthcare—but keeping up with these evolving technologies is easier said than done.

PathAI, a Boston-based healthcare technology company, has found that AI can help specialists quantify PD-L1 expression on both tumor cells and immune cells.

Cancer Research UK, one of the world’s largest charities focused on improving cancer treatments, has launched a new research network focused on advanced radiotherapy techniques, immunotherapies and AI.

Mateon Therapeutics, a California-based biopharmaceutical company, has completed its acquisition of PointR Data, a technology company focused on AI and other advanced technologies.